Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where authors phrase all words 'MOZES E' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 85 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Segal, R; Dayan, M; Zinger, H; Mozes, E
      Suppression of experimental systemic lupus erythematosus (SLE) in mice viaTNF inhibition by an anti-TNF alpha monoclonal antibody and by pentoxiphylline

      LUPUS
    2. Faber-Elmann, A; Grabovsky, V; Dayan, M; Sela, M; Alon, R; Mozes, E
      An altered peptide ligand inhibits the activities of matrix metalloproteinase-9 and phospholipase C, and inhibits T cell interactions with VCAM-1 induced in vivo by a myasthenogenic T cell epitope

      FASEB JOURNAL
    3. Eilat, E; Dayan, M; Zinger, H; Mozes, E
      The mechanism by which a peptide based on complementarity-determining region-1 of a pathogenic anti-DNA auto-Ab ameliorates experimental systemic lupus erythematosus

      PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
    4. Paas-Rozner, M; Sela, M; Mozes, E
      The nature of the active suppression of responses associated with experimental autoimmune myasthenia gravis by a dual altered peptide ligand administered by different routes

      PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
    5. Perez, J; Garcia, PM; Mozes, E; Bautista, MJ; Carrasco, L
      Immunohistochemical characterization of hepatic lesions associated with migrating larvae of Ascaris suum in pigs

      JOURNAL OF COMPARATIVE PATHOLOGY
    6. Faber-Elmann, A; Grabovsky, V; Dayan, M; Sela, M; Alon, R; Mozes, E
      Cytokine profile and T cell adhesiveness to endothelial selectins: in vivoinduction by a myasthenogenic T cell epitope and immunomodulation by a dual altered peptide ligand

      INTERNATIONAL IMMUNOLOGY
    7. Dayan, M; Segal, R; Globerson, A; Habut, B; Shearer, GM; Mozes, E
      Effect of aging on cytokine production in normal and experimental systemiclupus erythematosus-afflicted mice

      EXPERIMENTAL GERONTOLOGY
    8. Eilat, E; Zinger, H; Nyska, A; Mozes, E
      Prevention of systemic lupus erythematosus-like disease in (NZBxNZW)F1 mice by treating with CDR1-and CDR3-based peptides of a pathogenic autoantibody

      JOURNAL OF CLINICAL IMMUNOLOGY
    9. Dayan, M; Segal, R; Sthoeger, Z; Waisman, A; Brosh, N; Elkayam, O; Eilat, E; Fridkin, M; Mozes, E
      Immune response of SLE patients to peptides based on the complementarity determining regions of a pathogenic anti-DNA monoclonal antibody

      JOURNAL OF CLINICAL IMMUNOLOGY
    10. Eilat, E; Fridkin, M; Mozes, E
      A peptide based on the CDR1 of a pathogenic anti-DNA antibody is more efficient than its analogs in inhibiting autoreactive T cells

      IMMUNOBIOLOGY
    11. Brosh, N; Dayan, M; Fridkin, M; Mozes, E
      A peptide based on the CDR3 of an anti-DNA antibody of experimental SLE origin is also a dominant T-cell epitope in (NZBXNZW)F1 lupus-prone mice

      IMMUNOLOGY LETTERS
    12. Paas-Rozner, M; Dayan, M; Paas, Y; Changeux, JP; Wirguin, I; Sela, M; Mozes, E
      Oral administration of a dual analog of two myasthenogenic T cell epitopesdown-regulates experimental autoimmune myasthenia gravis in mice

      PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
    13. Tschetter, JR; Mozes, E; Shearer, GM
      Progression from acute to chronic disease in a murine parent-into-F-1 model of graft-versus-host disease

      JOURNAL OF IMMUNOLOGY
    14. Brosh, N; Eilat, E; Zinger, H; Mozes, E
      Characterization and role in experimental systemic lupus erythematosus of T-cell lines specific to peptides based on complementarity-determining region-1 and complementarity-determining region-3 of a pathogenic anti-DNA monoclonal antibody

      IMMUNOLOGY
    15. Brosh, N; Zinger, H; Fridkin, M; Mozes, E
      A peptide based on the sequence of the CDR3 of a murine anti-DNA mAb is a better modulator of experimental SLE than its single amino acid-substitutedanalogs

      CELLULAR IMMUNOLOGY
    16. Blank, M; Waisman, A; Mozes, E; Koike, T; Shoenfeld, Y
      Characteristics and pathogenic role of anti-beta 2-glycoprotein I single-chain Fv domains: induction of experimental antiphospholipid syndrome

      INTERNATIONAL IMMUNOLOGY
    17. Zisman, A; Lindner, A; Zisman, E; Lindner, U; Mozes, E
      Prostate-specific antigen induces proliferation of peripheral blood lymphocytes and cytokine secretion in benign prostate hypertrophy patients

      EUROPEAN UROLOGY
    18. Nezlin, R; Dayan, M; Zinger, H; Mozes, E
      DNA levels in immune complexes circulating in mice with induced systemic lupus erythematosus

      IMMUNOLOGY LETTERS
    19. Mendlovic, S; Mozes, E; Eilat, E; Doron, A; Lereya, J; Zakuth, V; Spirer, Z
      Immune activation in non-treated suicidal major depression

      IMMUNOLOGY LETTERS
    20. Kobayashi, S; Yoshida, K; Ward, JM; Letterio, JJ; Longenecker, G; Yaswen, L; Mittleman, B; Mozes, E; Roberts, AB; Karlsson, S; Kulkarni, AB
      beta(2)-microglobulin-deficient background ameliorates lethal phenotype ofthe TGF-beta 1 null mouse

      JOURNAL OF IMMUNOLOGY
    21. Singer, DS; Zinger, H; Kohn, LD; Mozes, E
      Differing MHC class I requirements for induction and propagation of experimental systemic lupus erythematosus

      EUROPEAN JOURNAL OF IMMUNOLOGY
    22. Mozes, E
      Experimental systemic lupus erythematosus: From a pathogenic autoantibody to immunomodulating peptides

      DECADE OF AUTOIMMUNITY
    23. Mozes, E; Sela, M
      The involvement of myasthenogenic T-cell epitopes and their analogs in theclinical manifestations and treatment of myasthenia gravis

      DECADE OF AUTOIMMUNITY
    24. Singer, DS; Howcroft, TK; Weissman, J; Brown, J; Kirshner, S; Mozes, E; Kohn, LD
      Regulation of MHC class I gene expression: A case study

      IMMUNOLOGIST
    25. ZISMAN A; LINDNER A; ZISMAN E; LINDNER U; MOZES E
      PROSTATE-SPECIFIC ANTIGEN INDUCES PROLIFERATION OF PERIPHERAL-BLOOD LYMPHOCYTES AND CYTOKINE SECRETION IN BENIGN PROSTATE HYPERTROPHY PATIENTS

      European cytokine network
    26. MOZES E; ZINGER H; KOHN LD; SINGER DS
      SPONTANEOUS AUTOIMMUNE-DISEASE IN (NZB X NZW)F-1 MICE IS AMELIORATED BY TREATMENT WITH METHIMAZOLE

      Journal of clinical immunology
    27. MOZES E; CORNELISSEN RL; HIRS GG; BOOM RM
      EXERGY ANALYSIS OF THE CONVENTIONAL TEXTILE WASHING PROCESS

      Energy conversion and management
    28. KATZLEVY Y; DAYAN M; WIRGUIN I; FRIDKIN M; SELA M; MOZES E
      SINGLE AMINO-ACID-ANALOGS OF A MYASTHENOGENIC PEPTIDE MODULATE SPECIFIC T-CELL RESPONSES AND PREVENT THE INDUCTION OF EXPERIMENTAL AUTOIMMUNE MYASTHENIA-GRAVIS

      Journal of neuroimmunology
    29. RUIZ PJ; WAISMAN A; MOZES E
      ANTI-T-CELL RECEPTOR THERAPY IN MURINE EXPERIMENTAL SYSTEMIC LUPUS-ERYTHEMATOSUS

      Immunology letters
    30. FABERELMANN A; PAASROZNER M; SELA M; MOZES E
      ALTERED PEPTIDE LIGANDS ACT AS PARTIAL AGONISTS BY INHIBITING PHOSPHOLIPASE-C ACTIVITY-INDUCED BY MYASTHENOGENIC T-CELL EPITOPES

      Proceedings of the National Academy of Sciences of the United Statesof America
    31. SINGER DS; MOZES E; KIRSHNER S; KOHN LD
      ROLE OF MHC CLASS-I MOLECULES IN AUTOIMMUNE-DISEASE

      Critical reviews in immunology
    32. DAYAN M; SEGAL R; MOZES E
      CYTOKINE MANIPULATION BY METHOTREXATE TREATMENT IN MURINE EXPERIMENTAL SYSTEMIC LUPUS-ERYTHEMATOSUS

      Journal of rheumatology
    33. CHAN CC; LI Q; MATTESON DM; MOZES E; SINGER DS
      EXPERIMENTAL BLEPHARITIS - ADOPTIVE TRANSFER AND APOPTOSIS

      Investigative ophthalmology & visual science
    34. MOZES E; ALLING D; MILLER MW; PAYNE SM; ZINGER H; VIA CS; SHEARER GM
      GENETIC-ANALYSIS OF EXPERIMENTALLY-INDUCED LUPUS IN MICE

      Clinical immunology and immunopathology
    35. SEGAL R; DAYAN M; GLOBERSON A; HABUT B; SHEARER GM; MOZES E
      EFFECT OF AGING ON CYTOKINE PRODUCTION IN NORMAL AND EXPERIMENTAL SYSTEMIC LUPUS-ERYTHEMATOSUS AFFLICTED MICE

      Mechanism of ageing and development
    36. KARNI A; ZISMAN E; KATZLEVY Y; PAASROZNER M; DAYAN M; BRAUTBAR C; ABRAMSKY O; SELA M; MOZES E
      REACTIVITY OF T-CELLS FROM SERONEGATIVE PATIENTS WITH MYASTHENIA-GRAVIS TO T-CELL EPITOPES OF THE HUMAN ACETYLCHOLINE-RECEPTOR

      Neurology
    37. WAISMAN A; RUIZ PJ; ISRAELI E; EILAT E; KONENWAISMAN S; ZINGER H; DAYAN M; MOZES E
      MODULATION OF MURINE SYSTEMIC LUPUS-ERYTHEMATOSUS WITH PEPTIDES BASEDON COMPLEMENTARITY-DETERMINING REGIONS OF A PATHOGENIC ANTI-DNA MONOCLONAL-ANTIBODY

      Proceedings of the National Academy of Sciences of the United Statesof America
    38. KATZLEVY Y; PAASROZNER M; KIRSHNER S; DAYAN M; ZISMAN E; FRIDKIN M; WIRGUIN I; SELA M; MOZES E
      A PEPTIDE COMPOSED OF TANDEM ANALOGS OF 2 MYASTHENOGENIC T-CELL EPITOPES INTERFERES WITH SPECIFIC AUTOIMMUNE RESPONSES

      Proceedings of the National Academy of Sciences of the United Statesof America
    39. SEGAL R; BERMAS BL; DAYAN M; KALUSH F; SHEARER GM; MOZES E
      KINETICS OF CYTOKINE PRODUCTION IN EXPERIMENTAL SYSTEMIC LUPUS-ERYTHEMATOSUS - INVOLVEMENT OF T-HELPER CELL-1-TYPE T-HELPER CELL-2-TYPE CYTOKINES IN DISEASE

      The Journal of immunology
    40. DAYAN M; ZINGER H; KALUSH F; MOR G; AMIRZALTZMAN Y; KOHEN F; STHOEGER Z; MOZES E
      THE BENEFICIAL-EFFECTS OF TREATMENT WITH TAMOXIFEN AND ANTI-ESTRADIOLANTIBODY ON EXPERIMENTAL SYSTEMIC LUPUS-ERYTHEMATOSUS ARE ASSOCIATED WITH CYTOKINE MODULATIONS

      Immunology
    41. KIRSHNER SL; WAISMAN A; ZISMAN E; BENNUN A; MOZES E
      T-CELL RECEPTOR EXPRESSION AND DIFFERENTIAL PROLIFERATIVE RESPONSES BY T-CELLS SPECIFIC TO A MYASTHENOGENIC PEPTIDE

      Cellular immunology
    42. WAISMAN A; RUIZ PJ; MOZES E
      VARIABLE REGIONS OF 2 MURINE ANTIBODIES THAT BIND THE SLE ASSOCIATED 16 6 IDIOTYPE/

      Lupus
    43. KIRSHNER SL; ZISMAN E; FRIDKIN M; SELA M; MOZES E
      ALTERED PEPTIDE LIGANDS OF A MYASTHENOGENIC EPITOPE AS MODULATORS OF SPECIFIC T-CELL RESPONSES

      Scandinavian journal of immunology
    44. MITTLEMAN BB; MORSE HC; PAYNE SM; SHEARER GM; MOZES E
      AMELIORATION OF EXPERIMENTAL SYSTEMIC LUPUS-ERYTHEMATOSUS (SLE) BY RETROVIRUS INFECTION

      Journal of clinical immunology
    45. TARTAKOVSKY B; BERMAS BL; STHOEGER Z; SHEARER GM; MOZES E
      DEFECTIVE MATERNAL-FETAL INTERACTION IN A MURINE AUTOIMMUNE MODEL

      Human reproduction
    46. STHOEGER ZM; TARTAKOVSKY B; FOGEL M; LASRI Y; MOZES E
      ANTICARDIOLIPIN, BUT NOT THE 16 6 ID ANTI-DNA ANTIBODY INDUCES PREGNANCY FAILURE/

      Immunology letters
    47. YEMINI SA; KLIGER S; MOZES E; YEMINI Y; OHSIE D
      HIGH-SPEED AND ROBUST EVENT CORRELATION

      IEEE communications magazine
    48. KARNI A; ZISMAN E; KATZLEVY Y; PAZ M; DAYAN M; ARGOVE Z; BRAUTBAR C; ABRAMSKY O; SELA M; MOZES E
      IMMUNE REACTIVITY OF SERONEGATIVE MYASTHENIA-GRAVIS PATIENTS TO MYASTHENOGENIC PEPTIDES (EPITOPES) OF THE HUMAN ACETYLCHOLINE-RECEPTOR

      Neurology
    49. ZISMAN E; KATZLEVY Y; DAYAN M; KIRSHNER SL; PAASROZNER M; KARNI A; ABRAMSKY O; BRAUTBAR C; FRIDKIN M; SELA M; MOZES E
      PEPTIDE ANALOGS TO PATHOGENIC EPITOPES OF THE HUMAN ACETYLCHOLINE-RECEPTOR ALPHA-SUBUNIT AS POTENTIAL MODULATORS OF MYASTHENIA-GRAVIS

      Proceedings of the National Academy of Sciences of the United Statesof America
    50. MOZES E; SEGAL R; STHOEGER Z; DAYAN M; ZINGER H; KOHN LD; SINGER DS
      MODULATION OF EXPERIMENTAL SYSTEMIC LUPUS-ERYTHEMATOSUS

      Israel journal of medical sciences
    51. WAISMAN A; ZISMAN E; MOZES E
      MHC CLASS II-MEDIATED T-CELL RESPONSE TO DNA

      Cellular immunology
    52. RUIZ PJ; ZINGER H; MOZES E
      EFFECT OF INJECTION OF ANTI-CD4 AND ANTI-CD8 MONOCLONAL-ANTIBODIES ONTHE DEVELOPMENT OF EXPERIMENTAL SYSTEMIC LUPUS-ERYTHEMATOSUS IN MICE

      Cellular immunology
    53. YASWEN L; KULKARNI AB; FREDRICKSON T; MITTLEMAN B; SCHIFFMANN R; PAYNE S; LONGENECKER G; MOZES E; KARLSSON S
      AUTOIMMUNE MANIFESTATIONS IN THE TRANSFORMING GROWTH-FACTOR-BETA-1 KNOCKOUT MOUSE

      Blood
    54. WAISMAN A; SHOENFELD Y; BLANK M; RUIZ PJ; MOZES E
      THE PATHOGENIC HUMAN MONOCLONAL ANTI-DNA THAT INDUCES EXPERIMENTAL SYSTEMIC LUPUS-ERYTHEMATOSUS IN MICE IS ENCODED BY A V(H)4 GENE SEGMENT

      International immunology
    55. STHOEGER Z; MOZES E
      THE BENEFICIAL EFFECT OF THE ESTROGEN ANTAGONIST TAMOXIFEN ON EXPERIMENTAL SYSTEMIC LUPUS-ERYTHEMATOSUS - REPLY

      Journal of rheumatology
    56. ZISMAN E; BRAUTBAR C; SELA M; ABRAMSKY O; BATTAT S; KIRSHNER SL; KATZLEVY Y; DAYAN M; MOZES E
      BINDING OF PEPTIDES OF THE HUMAN ACETYLCHOLINE-RECEPTOR ALPHA-SUBUNITTO HLA CLASS-II OF PATIENTS WITH MYASTHENIA-GRAVIS

      Human immunology
    57. ZISMAN A; ZISMAN E; LINDNER A; VELIKANOV S; SIEGEL YI; MOZES E
      AUTOANTIBODIES TO PROSTATE-SPECIFIC ANTIGEN IN PATIENTS WITH BENIGN PROSTATIC HYPERPLASIA

      The Journal of urology
    58. CHAN CC; GERY I; KOHN LD; NUSSENBLATT RB; MOZES E; SINGER DS
      PERIOCULAR INFLAMMATION IN MICE WITH EXPERIMENTAL SYSTEMIC LUPUS-ERYTHEMATOSUS - A NEW EXPERIMENTAL BLEPHARITIS AND ITS MODULATION

      The Journal of immunology
    59. NEZLIN R; MOZES E
      DETECTION OF ANTIGENS IN IMMUNE-COMPLEXES BY A DOT-BLOT ASSAY

      Journal of immunological methods
    60. SELA M; KIRSHNER SL; KATZLEVY Y; ZISMAN E; MOZES E
      DOMINANT EPITOPES AND SYNTHETIC PEPTIDES IN MYASTHENIA-GRAVIS

      Israel journal of medical sciences
    61. SEGAL R; DAYAN M; ZINGER H; MOZES E
      METHOTREXATE TREATMENT IN MURINE EXPERIMENTAL SYSTEMIC LUPUS-ERYTHEMATOSUS (SLE) - CLINICAL BENEFITS ASSOCIATED WITH CYTOKINE MANIPULATION

      Clinical and experimental immunology
    62. LEVITE M; ZINGER H; ZISMAN E; REISNER Y; MOZES E
      BENEFICIAL-EFFECTS OF BONE-MARROW TRANSPLANTATION ON THE SEROLOGICAL MANIFESTATIONS AND KIDNEY PATHOLOGY OF EXPERIMENTAL SYSTEMIC LUPUS-ERYTHEMATOSUS

      Cellular immunology
    63. MITTLEMAN BB; SHEARER GM; PAYNE S; WOLF S; MOZES E
      TREATMENT OF EXPERIMENTAL SLE WITH RECOMBINANT MURINE IL-12

      Arthritis and rheumatism
    64. AST G; GOLDBLATT D; WAISMAN A; SPERLING R; MOZES E; SPERLING J
      AN AUTOANTIBODY DERIVED FROM MICE WITH EXPERIMENTAL SYSTEMIC LUPUS-ERYTHEMATOSUS IS DIRECTED AGAINST THE ESSENTIAL SPLICING FACTOR SF53 4 -A POSSIBLE ROLE FOR LARGE NUCLEAR RIBONUCLEOPROTEIN-PARTICLES IN AUTOIMMUNE DISORDERS/

      International immunology
    65. ZISMAN E; MOZES E
      PROCESSING REQUIREMENTS OF 2 ACETYLCHOLINE-RECEPTOR DERIVED PEPTIDES FOR BINDING TO ANTIGEN-PRESENTING CELLS AND STIMULATION OF MURINE T-CELL LINES

      International immunology
    66. SEGAL R; GLOBERSON A; ZINGER H; MOZES E
      INHIBITION OF AUTOANTIBODY PRODUCTION IN EXPERIMENTAL SLE BY PREIMMUNIZATION WITH DNA

      Autoimmunity
    67. BERMAS BL; PETRI M; BERZOFSKY JA; WAISMAN A; SHEARER GM; MOZES E
      BINDING OF GLYCOPROTEIN-120 AND PEPTIDES FROM THE HIV-1 ENVELOPE BY AUTOANTIBODIES IN MICE WITH EXPERIMENTALLY-INDUCED SYSTEMIC LUPUS-ERYTHEMATOSUS AND IN PATIENTS WITH THE DISEASE

      AIDS research and human retroviruses
    68. STHOEGER ZM; BENTWICH Z; ZINGER H; MOZES E
      THE BENEFICIAL EFFECT OF THE ESTROGEN ANTAGONIST, TAMOXIFEN, ON EXPERIMENTAL SYSTEMIC LUPUS-ERYTHEMATOSUS

      Journal of rheumatology
    69. KALUSH F; RIMON E; KELLER A; MOZES E
      NEONATAL LUPUS-ERYTHEMATOSUS WITH CARDIAC INVOLVEMENT IN OFFSPRING OFMOTHERS WITH EXPERIMENTAL SYSTEMIC LUPUS-ERYTHEMATOSUS

      Journal of clinical immunology
    70. RUIZ PJ; ZINGER H; MOZES E
      INDUCTION OF EXPERIMENTAL SYSTEMIC LUPUS-ERYTHEMATOSUS IN MICE BY IMMUNIZATION WITH THE F(AB')(2)-FRAGMENT OF THE HUMAN ANTI-DNA MONOCLONAL-ANTIBODY CARRYING THE 16 6-IDIOTYPE/

      Immunology letters
    71. CHAN CC; GERY I; NUSSENBLATT RB; MOZES E; SINGER DS
      PERIOCULAR INFLAMMATION IN MICE WITH EXPERIMENTAL SYSTEMIC LUPUS-ERYTHEMATOSUS (SLE) - A NEW EXPERIMENTAL EYE DISEASE AND ITS MODULATION

      Investigative ophthalmology & visual science
    72. SINGER DS; KOHN LD; ZINGER H; MOZES E
      METHIMAZOLE PREVENTS INDUCTION OF EXPERIMENTAL SYSTEMIC LUPUS-ERYTHEMATOSUS IN MICE

      The Journal of immunology
    73. MOZES E
      THE ROLE OF GENETIC-FACTORS IN AUTOIMMUNITY

      Israel journal of medical sciences
    74. ZISMAN E; SELA M; BENNUN A; MOZES E
      DICHOTOMY BETWEEN THE T-CELL AND THE B-CELL EPITOPES OF THE SYNTHETICPOLYPEPTIDE (T,G)-A--L

      European Journal of Immunology
    75. KIRSHNER SL; KATZLEVY Y; WIRGUIN I; ARGOV Z; MOZES E
      FINE SPECIFICITY OF T-CELL LINES AND CLONES THAT ARE CAPABLE OF INDUCING AUTOIMMUNE MANIFESTATIONS IN MICE

      Cellular immunology
    76. YASWEN L; KULKARNI AB; WARD J; SCHIFFMANN R; MOZES E; KARLSSON S
      POTENTIAL AUTOIMMUNE ETIOLOGY IN TGF-BETA-1 KNOCKOUT MOUSE IMMUNE DYSREGULATION

      Blood
    77. WAISMAN A; MENDLOVIC S; RUIZ PJ; ZINGER H; MESHORER A; MOZES E
      THE ROLE OF THE 16 6 IDIOTYPE NETWORK IN THE INDUCTION AND MANIFESTATIONS OF SYSTEMIC LUPUS-ERYTHEMATOSUS/

      International immunology
    78. GEYER O; NEUDORFER M; LAZAR M; DAYAN M; MOZES E
      CELLULAR-SENSITIVITY IN ALLERGIC BLEPHAROCONJUNCTIVITIS DUE TO PHENYLEPHRINE EYE DROPS

      Graefe's archive for clinical and experimental ophthalmology
    79. LEVITE M; ZINGER H; MOZES E; REISNER Y
      SYSTEMIC LUPUS ERYTHEMATOSUS-RELATED AUTOANTIBODY PRODUCTION IN MICE IS DETERMINED BY BONE-MARROW-DERIVED CELLS

      Bone marrow transplantation
    80. LYTTON SD; MOZES E; JAFFE CL
      EFFECT OF MACROPHAGE INFECTION BY LEISHMANIA ON THE PROLIFERATION OF AN ANTIGEN-SPECIFIC T-CELL LINE, TPB1, TO A NONPARASITE ANTIGEN

      Parasite immunology
    81. MOZES E; KOHN LD; HAKIM F; SINGER DS
      RESISTANCE OF MHC CLASS-I-DEFICIENT MICE TO EXPERIMENTAL SYSTEMIC LUPUS-ERYTHEMATOSUS

      Science
    82. KATZLEVY Y; KIRSHNER SL; SELA M; MOZES E
      INHIBITION OF T-CELL REACTIVITY TO MYASTHENOGENIC EPITOPES OF THE HUMAN ACETYLCHOLINE-RECEPTOR BY SYNTHETIC ANALOGS

      Proceedings of the National Academy of Sciences of the United Statesof America
    83. STHOEGER ZM; MOZES E; TARTAKOVSKY B
      ANTICARDIOLIPIN ANTIBODIES INDUCE PREGNANCY FAILURE BY IMPAIRING EMBRYONIC IMPLANTATION

      Proceedings of the National Academy of Sciences of the United Statesof America
    84. WAISMAN A; MOZES E
      VARIABLE REGION SEQUENCES OF AUTOANTIBODIES FROM MICE WITH EXPERIMENTAL SYSTEMIC LUPUS-ERYTHEMATOSUS

      European Journal of Immunology
    85. STHOEGER Z; TARTAKOVSKY B; FOGEL M; MOZES E
      ANTICARDIOLIPIN ANTIBODIES IMPAIR PREIMPLANTATION EMBRYONIC-DEVELOPMENT

      Arthritis and rheumatism


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 04/08/20 alle ore 19:44:42